» Articles » PMID: 27678290

Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study

Overview
Specialty Geriatrics
Date 2016 Sep 29
PMID 27678290
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nonhuman studies suggest a protective effect of caffeine on cognition. Although human literature remains less consistent, reviews suggest a possible favorable relationship between caffeine consumption and cognitive impairment or dementia. We investigated the relationship between caffeine intake and incidence of cognitive impairment or probable dementia in women aged 65 and older from the Women's Health Initiative Memory Study.

Methods: All women with self-reported caffeine consumption at enrollment were included (N = 6,467). In 10 years or less of follow-up with annual assessments of cognitive function, 388 of these women received a diagnosis of probable dementia based on a 4-phase protocol that included central adjudication. We used proportional hazards regression to assess differences in the distributions of times until incidence of probable dementia or composite cognitive impairment among women grouped by baseline level of caffeine intake, adjusting for risk factors (hormone therapy, age, race, education, body mass index, sleep quality, depression, hypertension, prior cardiovascular disease, diabetes, smoking, and alcohol consumption).

Results: Women consuming above median levels (mean intake = 261mg) of caffeine intake for this group were less likely to develop incident dementia (hazard ratio = 0.74, 95% confidence interval [0.56, 0.99], p = .04) or any cognitive impairment (hazard ratio = 0.74, confidence interval [0.60, 0.91], p = .005) compared to those consuming below median amounts (mean intake = 64mg) of caffeine for this group.

Conclusion: Our findings suggest lower odds of probable dementia or cognitive impairment in older women whose caffeine consumption was above median for this group and are consistent with the existing literature showing an inverse association between caffeine intake and age-related cognitive impairment.

Citing Articles

High Doses of Caffeine-Induced Cerebral Infarction Leading to Partial Locked-In Syndrome in a Young Adult: A Novel Association?.

Sinha V, Lam L, Nguyen M Case Rep Neurol. 2024; 16(1):115-121.

PMID: 39015836 PMC: 11250471. DOI: 10.1159/000538950.


Association between sleep duration and subjective memory complaints: A large-scale cross-sectional study based on NHANES.

Xie X, Zheng X, Mei L, Hu Y, Liu J, Ma G Prev Med Rep. 2024; 43:102790.

PMID: 38975279 PMC: 11225028. DOI: 10.1016/j.pmedr.2024.102790.


Coffee consumption and all-cause and cardiovascular mortality in older adults: should we consider cognitive function?.

Lin F, Shi Y, Zou X, Wang H, Fu S, Wang X Front Nutr. 2023; 10:1150992.

PMID: 37941773 PMC: 10628482. DOI: 10.3389/fnut.2023.1150992.


Caffeine for Prevention of Alzheimer's Disease: Is the A Adenosine Receptor Its Target?.

Merighi S, Travagli A, Nigro M, Pasquini S, Cappello M, Contri C Biomolecules. 2023; 13(6).

PMID: 37371547 PMC: 10296091. DOI: 10.3390/biom13060967.


Complementary and Alternative Medicine Approaches in Alzheimer Disease and Other Neurocognitive Disorders.

Beversdorf D, Crosby H, Shenker J Mo Med. 2023; 120(1):70-78.

PMID: 36860601 PMC: 9970340.


References
1.
Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N . Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis. 2010; 20 Suppl 1:S187-204. DOI: 10.3233/JAD-2010-091387. View

2.
Shumaker S, Reboussin B, Espeland M, Rapp S, McBee W, DAILEY M . The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials. 1999; 19(6):604-21. DOI: 10.1016/s0197-2456(98)00038-5. View

3.
Cao C, Wang L, Lin X, Mamcarz M, Zhang C, Bai G . Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice. J Alzheimers Dis. 2011; 25(2):323-35. DOI: 10.3233/JAD-2011-110110. View

4.
Arendash G, Cao C . Caffeine and coffee as therapeutics against Alzheimer's disease. J Alzheimers Dis. 2010; 20 Suppl 1:S117-26. DOI: 10.3233/JAD-2010-091249. View

5.
Rosso A, Mossey J, Lippa C . Caffeine: neuroprotective functions in cognition and Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2009; 23(5):417-22. PMC: 10846190. DOI: 10.1177/1533317508320083. View